US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist

25.060
-0.070-0.28%

Close Oct 31 16:00 ET

3.88BMarket Cap36.85P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

113.18%5.54M

86.30%-8.21M

82.17%-31.41M

44.66%-13.21M

342.66%83.7M

14.48%-42.01M

12.79%-59.9M

40.41%-176.17M

72.53%-23.87M

48.67%-34.5M

Net income from continuing operations

114.45%6.88M

72.71%-10.71M

106.39%12.67M

72.80%-14.42M

418.08%113.93M

-17.52%-47.61M

43.15%-39.23M

43.02%-198.34M

43.22%-52.99M

58.18%-35.82M

Depreciation and amortization

-15.29%72K

-32.23%82K

-17.86%423K

-27.78%91K

-2.33%126K

-35.11%85K

-6.20%121K

4.25%515K

-5.26%126K

0.00%129K

Other non cash items

-10.75%1.2M

0.00%1.01M

0.25%4.45M

19.80%1.31M

-53.17%790K

93.08%1.34M

4.66%1.01M

85.28%4.44M

83.58%1.1M

176.56%1.69M

Change In working capital

-30.44%-10.67M

78.58%-6.07M

-5,040.19%-84.66M

-147.33%-8.05M

-447.47%-40.11M

2.85%-8.18M

-871.66%-28.32M

86.52%-1.65M

294.33%17.01M

-305.61%-7.33M

-Change in receivables

-110.20%-18.63M

-61.07%-13.89M

-3,778.40%-51.09M

---11.77M

-24,913.64%-21.84M

-1,188.57%-8.86M

-1,870.64%-8.62M

200.00%1.39M

--0

119.43%88K

-Change in inventory

-29.82%-2.56M

-37.17%-36.93M

---36.94M

---5.51M

---2.54M

---1.97M

---26.92M

--0

-Change in payables and accrued expense

-3.44%8.96M

308.01%40.22M

101.74%192K

-84.39%2.56M

-253.69%-21.51M

182.95%9.28M

196.93%9.86M

-168.85%-11.01M

321.07%16.43M

-168.95%-6.08M

-Change in other current assets

115.69%1.05M

156.81%1.49M

-134.60%-2.83M

2,122.42%7.53M

-394.81%-1.05M

-616.83%-6.69M

-138.81%-2.62M

196.16%8.18M

127.06%339K

92.52%-212K

-Change in other current liabilities

-87.27%14K

9,280.77%2.44M

645.45%300K

-80.21%56K

109.97%108K

-84.24%110K

-44.68%26K

99.70%-55K

102.49%283K

43.92%-1.08M

-Change in other working capital

1,410.53%498K

1,684.21%602K

3,857.24%5.71M

-2,336.84%-926K

17,765.79%6.71M

0.00%-38K

0.00%-152K

0.00%-38K

Cash from discontinued investing activities

Operating cash flow

113.18%5.54M

86.30%-8.21M

82.17%-31.41M

44.66%-13.21M

342.66%83.7M

14.48%-42.01M

12.79%-59.9M

40.41%-176.17M

72.53%-23.87M

48.67%-34.5M

Investing cash flow

Cash flow from continuing investing activities

-94.21%1.77M

-50.05%-9.26M

-153.09%-50.65M

-375.09%-44.76M

-911.00%-30.23M

193.87%30.5M

85.88%-6.17M

-5,928.01%-20.01M

394.80%16.27M

-373.85%-2.99M

Net PPE purchase and sale

----

--0

----

96.51%-14K

96.25%-3K

94.94%-4K

Net investment purchase and sale

-94.21%1.77M

-50.05%-9.26M

-153.27%-50.65M

-375.04%-44.76M

-912.36%-30.23M

193.87%30.5M

85.87%-6.17M

-29,084.06%-20M

383.14%16.27M

-440.94%-2.99M

Cash from discontinued investing activities

Investing cash flow

-94.21%1.77M

-50.05%-9.26M

-153.09%-50.65M

-375.09%-44.76M

-911.00%-30.23M

193.87%30.5M

85.88%-6.17M

-5,928.01%-20.01M

394.80%16.27M

-373.85%-2.99M

Financing cash flow

Cash flow from continuing financing activities

-99.71%135K

-99.96%10K

18,694.63%72.71M

-102.04%-1K

53.09%421K

34,749.63%47.05M

3,069.18%25.24M

-100.94%-391K

-99.91%49K

103.74%275K

Net issuance payments of debt

----

2,664.10%25M

--0

2,664.10%25M

-102.44%-975K

--0

Net common stock issuance

----

--46.3M

---1K

--1K

----

--0

Proceeds from stock option exercised by employees

-82.02%135K

-97.25%10K

162.67%1.53M

--0

52.73%420K

456.30%751K

190.40%363K

170.37%584K

--49K

450.00%275K

Net other financing activities

----

---125K

--0

----

---125K

----

Cash from discontinued financing activities

Financing cash flow

-99.71%135K

-99.96%10K

18,694.63%72.71M

-102.04%-1K

53.09%421K

34,749.63%47.05M

3,069.18%25.24M

-100.94%-391K

-99.91%49K

103.74%275K

Net cash flow

Beginning cash position

22.35%76.77M

-9.04%94.22M

-65.49%103.58M

36.94%152.18M

-33.74%98.29M

-66.44%62.75M

-65.49%103.58M

-45.89%300.15M

-66.10%111.13M

-63.19%148.34M

Current changes in cash

-79.08%7.44M

57.26%-17.45M

95.24%-9.36M

-667.56%-57.97M

244.84%53.9M

192.08%35.54M

63.93%-40.83M

22.77%-196.57M

72.66%-7.55M

50.51%-37.21M

End cash Position

-14.33%84.2M

22.35%76.77M

-9.04%94.22M

36.94%152.18M

-33.74%98.29M

-66.44%62.75M

-65.49%103.58M

-66.10%111.13M

Free cash flow

113.18%5.54M

86.30%-8.21M

82.17%-31.41M

44.67%-13.21M

342.63%83.7M

14.48%-42.01M

12.80%-59.9M

40.49%-176.18M

72.56%-23.87M

48.72%-34.5M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	113.18%5.54M	86.30%-8.21M	82.17%-31.41M	44.66%-13.21M	342.66%83.7M	14.48%-42.01M	12.79%-59.9M	40.41%-176.17M	72.53%-23.87M	48.67%-34.5M
Net income from continuing operations	114.45%6.88M	72.71%-10.71M	106.39%12.67M	72.80%-14.42M	418.08%113.93M	-17.52%-47.61M	43.15%-39.23M	43.02%-198.34M	43.22%-52.99M	58.18%-35.82M
Depreciation and amortization	-15.29%72K	-32.23%82K	-17.86%423K	-27.78%91K	-2.33%126K	-35.11%85K	-6.20%121K	4.25%515K	-5.26%126K	0.00%129K
Other non cash items	-10.75%1.2M	0.00%1.01M	0.25%4.45M	19.80%1.31M	-53.17%790K	93.08%1.34M	4.66%1.01M	85.28%4.44M	83.58%1.1M	176.56%1.69M
Change In working capital	-30.44%-10.67M	78.58%-6.07M	-5,040.19%-84.66M	-147.33%-8.05M	-447.47%-40.11M	2.85%-8.18M	-871.66%-28.32M	86.52%-1.65M	294.33%17.01M	-305.61%-7.33M
-Change in receivables	-110.20%-18.63M	-61.07%-13.89M	-3,778.40%-51.09M	---11.77M	-24,913.64%-21.84M	-1,188.57%-8.86M	-1,870.64%-8.62M	200.00%1.39M	--0	119.43%88K
-Change in inventory	-29.82%-2.56M	-37.17%-36.93M	---36.94M	---5.51M	---2.54M	---1.97M	---26.92M	--0	--0	--0
-Change in payables and accrued expense	-3.44%8.96M	308.01%40.22M	101.74%192K	-84.39%2.56M	-253.69%-21.51M	182.95%9.28M	196.93%9.86M	-168.85%-11.01M	321.07%16.43M	-168.95%-6.08M
-Change in other current assets	115.69%1.05M	156.81%1.49M	-134.60%-2.83M	2,122.42%7.53M	-394.81%-1.05M	-616.83%-6.69M	-138.81%-2.62M	196.16%8.18M	127.06%339K	92.52%-212K
-Change in other current liabilities	-87.27%14K	9,280.77%2.44M	645.45%300K	-80.21%56K	109.97%108K	-84.24%110K	-44.68%26K	99.70%-55K	102.49%283K	43.92%-1.08M
-Change in other working capital	1,410.53%498K	1,684.21%602K	3,857.24%5.71M	-2,336.84%-926K	17,765.79%6.71M	0.00%-38K	0.00%-38K	0.00%-152K	0.00%-38K	0.00%-38K
Cash from discontinued investing activities
Operating cash flow	113.18%5.54M	86.30%-8.21M	82.17%-31.41M	44.66%-13.21M	342.66%83.7M	14.48%-42.01M	12.79%-59.9M	40.41%-176.17M	72.53%-23.87M	48.67%-34.5M
Investing cash flow
Cash flow from continuing investing activities	-94.21%1.77M	-50.05%-9.26M	-153.09%-50.65M	-375.09%-44.76M	-911.00%-30.23M	193.87%30.5M	85.88%-6.17M	-5,928.01%-20.01M	394.80%16.27M	-373.85%-2.99M
Net PPE purchase and sale	----	----	--0	--0	----	----	----	96.51%-14K	96.25%-3K	94.94%-4K
Net investment purchase and sale	-94.21%1.77M	-50.05%-9.26M	-153.27%-50.65M	-375.04%-44.76M	-912.36%-30.23M	193.87%30.5M	85.87%-6.17M	-29,084.06%-20M	383.14%16.27M	-440.94%-2.99M
Cash from discontinued investing activities
Investing cash flow	-94.21%1.77M	-50.05%-9.26M	-153.09%-50.65M	-375.09%-44.76M	-911.00%-30.23M	193.87%30.5M	85.88%-6.17M	-5,928.01%-20.01M	394.80%16.27M	-373.85%-2.99M
Financing cash flow
Cash flow from continuing financing activities	-99.71%135K	-99.96%10K	18,694.63%72.71M	-102.04%-1K	53.09%421K	34,749.63%47.05M	3,069.18%25.24M	-100.94%-391K	-99.91%49K	103.74%275K
Net issuance payments of debt	----	----	2,664.10%25M	--0	--0	--0	2,664.10%25M	-102.44%-975K	--0	--0
Net common stock issuance	----	----	--46.3M	---1K	--1K	----	----	--0	--0	--0
Proceeds from stock option exercised by employees	-82.02%135K	-97.25%10K	162.67%1.53M	--0	52.73%420K	456.30%751K	190.40%363K	170.37%584K	--49K	450.00%275K
Net other financing activities	----	----	---125K	--0	----	----	---125K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-99.71%135K	-99.96%10K	18,694.63%72.71M	-102.04%-1K	53.09%421K	34,749.63%47.05M	3,069.18%25.24M	-100.94%-391K	-99.91%49K	103.74%275K
Net cash flow
Beginning cash position	22.35%76.77M	-9.04%94.22M	-65.49%103.58M	36.94%152.18M	-33.74%98.29M	-66.44%62.75M	-65.49%103.58M	-45.89%300.15M	-66.10%111.13M	-63.19%148.34M
Current changes in cash	-79.08%7.44M	57.26%-17.45M	95.24%-9.36M	-667.56%-57.97M	244.84%53.9M	192.08%35.54M	63.93%-40.83M	22.77%-196.57M	72.66%-7.55M	50.51%-37.21M
End cash Position	-14.33%84.2M	22.35%76.77M	-9.04%94.22M	-9.04%94.22M	36.94%152.18M	-33.74%98.29M	-66.44%62.75M	-65.49%103.58M	-65.49%103.58M	-66.10%111.13M
Free cash flow	113.18%5.54M	86.30%-8.21M	82.17%-31.41M	44.67%-13.21M	342.63%83.7M	14.48%-42.01M	12.80%-59.9M	40.49%-176.18M	72.56%-23.87M	48.72%-34.5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data